Nova Laboratories
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Jayempi | Azathioprine | 2021-06-21 | ||
| Purixan | Mercaptopurine | 2014-04-28 | ||
| Xaluprine (previously mercaptopurine nova laboratories) | Mercaptopurine | 2012-03-09 | ||
| Xromi | Hydroxycarbamide, Hydroxyurea | 2019-07-01 | ||
| Qaialdo | Spironolactone | 2023-05-26 | 2036 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use